Pfizer's revenue falls as COVID sales and vaccine recommendations continue to fade

Core Insights - The full-year outlook for the company was lifted, indicating improved expectations for future performance [1] Group 1 - Despite the positive adjustment in the full-year outlook, the stock experienced a decline [1]